After initial phase, most clients move to monthly maintenance treatments
CagriSema adds cagrilintide to semaglutide, aiming to enhance weight loss and appetite suppression more than semaglutide alone
This process also encourages healthier cell renewal, resulting in improved skin texture, better clarity, and overall skin health
While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
Can I adjust my cagrilintide dosage schedule
We invite you to experience the BUBS difference for yourself